aryx therapeutics inc (ARYX:OTC US)
Paul Goddard Ph.D.
Chairman and Chief Executive Officer, ARYx Therapeutics, Inc.
|Age||Total Calculated Compensation||This person is connected to 33 board members in 6 different organizations across 10 different industries.|
See Board Relationships
Dr. Paul Goddard, Ph.D. has been the Life Science Advisor of CM Capital Investments Pty Ltd since 2002. Dr. Goddard specific expertise in high level commercial strategy and transaction activities, particularly within the biotechnology and pharmaceutical sector. He has served the Chairman of Aryx Therapeutics Inc. since August 2003 and has served Chief Executive Officer since February 2005. Dr. Goddard served as a Consultant of Adolor Corporation from August 2003 to July ...
6300 Dumbarton CirclePhone: 510-585-2200
Fremont, California 94555
Board Members Memberships*
Former Non-Executive Director
Former Chairman, Chief Executive Officer and President
Former Director, Member of Nominating Committee and Member of Audit Committee
Lead Independent Director and Chairman of Compensation Committee
Director and Member of Compensation Committee
Member of the Board
Former Chairman of the Board
Chairman and Chief Executive Officer
University Of London
Queen Elizabeth College, University Of London
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Peter M. Hecht Ph.D.||Co-Founder, Chief Executive Officer and Director|
Ironwood Pharmaceuticals, Inc.
|Peter S. Greenleaf||Chief Executive Officer, Director, Member of Commercialization Committee and Member of Science & Technology Committee|
Sucampo Pharmaceuticals, Inc.
|Eduardo Javier Sanchiz Yrazu||Chief Executive Officer, Member of Management Board, Chief Executive of Corporate Development & Finance, Executive Director and Member of Compliance Committee|
|--||Compensation as of Fiscal Year 2013.|